MedPath

Investigating the effect of saffron on cognitive impairment in schizophrenic patients treated with electric shock

Phase 2
Recruiting
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20240416061505N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Age 18 to 60 years
Schizophrenic disorder based on DSM-5 criteria
A candidate for receiving bilateral electroshock therapy
Minimum literacy
Ability to communicate verbally
Not suffering from mental disability or serious cognitive disorders

Exclusion Criteria

Epilepsy and other neurological disorders
Coagulation disorders
Dependence or abuse of alcohol and drugs in the last 6 months (except nicotine and caffeine)
History of saffron consumption since 3 months ago
History of drug sensitivity
Pregnancy and breastfeeding
Patients who had ECT at least in the 6 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychological disorder. Timepoint: Before the start of the ECT and again 24 hours after the fourth session of ECT and 72 hours after the end of the ECT. Method of measurement: Mini–mental state examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath